Trigger inducible tertiary lymphoid structure formation using covalent organic frameworks for cancer immunotherapy

Liang Zhang1,2, Boxin Zhang1, Meng-Jie Zhang1

  • 1State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Frontier Science Center for Immunology and Metabolism, Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan, China.

Nature Communications
|January 3, 2025
PubMed
Summary

Researchers developed a novel covalent organic framework (COF) to induce tertiary lymphoid structures (TLS) formation, enhancing cancer immunotherapy. This COF-mediated phototherapy effectively eradicates tumors and prevents recurrence by promoting immune cell activity.

Related Concept Videos